Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Glioma
Related studies linked through entity extraction aliases.
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
- Status
- TERMINATED
- Phase
- PHASE2
131-I-TM-601 Study in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
- Status
- TERMINATED
- Phase
- PHASE2
Experience of Brain Tumor Caregivers
- Status
- COMPLETED
- Phase
- N/A
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
A Family Study of Adults With Glioma
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of ECO-4601 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
- Status
- UNKNOWN
- Phase
- NA
Cognitive Rehabilitation of Glioma Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
- Status
- COMPLETED
- Phase
- N/A
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Prolonged Daily Temozolomide for Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)
- Status
- COMPLETED
- Phase
- N/A
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- N/A
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2